Zika & Pregnancy Risks Explained: Microcephaly, CZS & What You Need to Know
Zika virus causes mild illness in most adults — but can be catastrophic for unborn children. Here's what pregnant people and their partners must know.
The Paradox of Zika: Mild for Adults, Catastrophic for Fetuses
Approximately 80% of Zika virus infections in adults are completely asymptomatic. Those who do develop symptoms experience a mild, self-limiting illness — low fever, rash, joint pain, and conjunctivitis lasting 2–7 days. It would be easy to dismiss Zika as medically unimportant.
But in 2015–2016, Brazil reported a dramatic surge in infants born with microcephaly — abnormally small heads indicating severely underdeveloped brains. Epidemiological investigation confirmed the culprit: Zika virus, which had been spreading explosively through Aedes aegypti mosquitoes. The connection between a seemingly benign virus and devastating congenital birth defects shocked the global health community.
WHO declared a Public Health Emergency of International Concern (PHEIC) in February 2016. By the time the epidemic wave subsided, thousands of children had been born with Congenital Zika Syndrome across Brazil, Colombia, and other affected countries. Many of these children will require lifelong care.
How Zika Crosses the Placenta
Zika virus has a remarkable ability to cross the placental barrier — unlike most flaviviruses, which are blocked there. The mechanism involves the virus binding to specific cellular receptors expressed on placental cells (Hofbauer cells, trophoblasts). Once past the placental barrier, Zika preferentially infects neural progenitor cells — the stem cells of the developing brain.
The consequences in a developing fetus are severe:
- Neural progenitor cell death → reduced neuron production → microcephaly
- Disruption of neuronal migration → cortical malformation, gyral abnormalities
- Vascular injury → intracranial calcifications (visible on ultrasound)
- Eye development disruption → ocular abnormalities (optic nerve hypoplasia, retinal mottling)
- Joint contractures (arthrogryposis) from neurological damage
The first trimester is the highest-risk period — when the developing brain is most vulnerable. However, Zika can cause damage throughout pregnancy; second and third trimester infections have also resulted in fetal harm.
Congenital Zika Syndrome (CZS): What It Means
The constellation of birth defects caused by prenatal Zika infection is now defined as Congenital Zika Syndrome (CZS), which includes:
- Microcephaly: Head circumference more than 2 standard deviations below the mean for gestational age. Severe microcephaly (>3 SD below mean) is associated with the worst outcomes.
- Intracranial calcifications: Calcium deposits in the periventricular region and basal ganglia — visible on ultrasound and CT.
- Cortical and subcortical malformations: Including lissencephaly (smooth brain), pachygyria, and white matter changes.
- Ventriculomegaly: Enlarged brain ventricles indicating brain tissue loss.
- Eye abnormalities: Cataracts, optic nerve hypoplasia, retinal damage.
- Joint and limb abnormalities: Arthrogryposis (fixed joint contractures).
Children with CZS face profound disabilities: intellectual impairment, seizure disorders, spasticity, hearing loss, feeding difficulties, and visual impairment. Many require intensive multidisciplinary lifelong care — a massive burden on affected families and health systems in Brazil, Colombia, and other affected countries.
Beyond Microcephaly: The Spectrum of CZS
Early reports focused on microcephaly, but CZS affects children with normal-appearing head circumferences too. Long-term follow-up of children exposed to Zika in utero has revealed: epilepsy, sleep disorders, dysphagia (difficulty swallowing), profound developmental delay, and behavioral problems — even in children who appeared neurologically normal at birth. The full burden of CZS continues to emerge as affected cohorts age.
Sexual Transmission: The Unique Feature of Zika
Zika was the first mosquito-borne virus confirmed to also be sexually transmitted — a critical discovery for pregnancy safety. The virus persists in semen far longer than in blood:
- Zika RNA detected in semen up to 188 days after symptom onset in documented cases
- Live infectious virus confirmed in semen for up to ~69 days
- WHO/CDC recommendation: use condoms for at least 3 months after returning from Zika-endemic areas (regardless of symptoms)
- Female-to-male sexual transmission is documented but appears less common
- Vaginal, anal, and oral transmission have all been documented
For pregnant people: if your sexual partner has traveled to or lives in a Zika-endemic area, condom use for the entire duration of pregnancy is recommended, or abstinence from sexual activity with that partner.
Guillain-Barré Syndrome: The Adult Complication
In adults, Zika virus can trigger Guillain-Barré Syndrome (GBS) — an autoimmune condition where the immune system attacks the peripheral nervous system, causing rapidly progressing weakness and potential paralysis. The incidence is estimated at approximately 2 per 10,000 Zika infections.
GBS following Zika has a better prognosis than other GBS triggers — most patients recover significantly, though the process can take months and may require ICU-level respiratory support in severe cases (15–20% require mechanical ventilation).
Travel Advice for Pregnant People
- Avoid all non-essential travel to areas with active Zika transmission during pregnancy
- If travel is unavoidable: use DEET (20–30%) repellent, wear long sleeves and pants, stay in air-conditioned or well-screened accommodations, use bed nets
- Partners who travel to Zika areas should use condoms for the entire pregnancy
- Testing: Zika RT-PCR on serum/urine within 2 weeks of exposure; IgM serology after that period
- If infection confirmed: serial fetal ultrasounds every 3–4 weeks to monitor fetal head growth; referral to fetal medicine specialist
Current Zika Risk Areas
After the acute 2015–2016 epidemic subsided (as population immunity built up in affected areas), Zika cases declined substantially. However, Zika remains endemic and active in parts of:
- Latin America (Brazil, Colombia, Venezuela, Peru, and neighbors)
- Caribbean islands
- Pacific Islands (Micronesia, French Polynesia, Fiji)
- Parts of Southeast Asia and South Asia
- Parts of sub-Saharan Africa
The risk of a new epidemic wave remains — particularly if Zika spreads to naive populations in Africa or Asia where the Aedes vector is present but population immunity is low. Check the CDC and WHO travel health advisories for current country-specific risk assessments before travel.
Testing During Pregnancy
| Test | When to use | What it detects |
|---|---|---|
| Zika RT-PCR (serum + urine) | Within 2 weeks of exposure/symptoms | Active viral infection |
| Zika IgM serology | 2 weeks to 12 weeks after exposure | Recent Zika infection (may cross-react with dengue) |
| Plaque Reduction Neutralization Test (PRNT) | To confirm positive IgM | Confirms Zika-specific antibodies |
| Fetal ultrasound | Serial monitoring if exposure confirmed | Fetal head growth, intracranial anatomy, calcifications |
Vaccine Development: Where Are We?
No Zika vaccine is currently approved for general use. The 2016 PHEIC galvanized development of multiple candidates, but the rapid decline of the epidemic reduced the feasibility of large Phase 3 efficacy trials (requiring sufficient cases to measure protection).
Candidates in various stages of development include: mRNA vaccines (Moderna mRNA-1893 — promising Phase 2 results), NIH/Inovio DNA vaccine (VRC5283/GLS-5700), inactivated whole-virus vaccines (ZPIV), and subunit vaccines. All face the challenge of needing to demonstrate efficacy in the absence of a large ongoing outbreak.
Get Outbreak Alerts
regularly updated Zika and infectious disease outbreak notifications, free to your inbox.
Frequently Asked Questions
No. Not every Zika infection during pregnancy results in fetal harm. Studies suggest the risk of significant birth defects is approximately 5–14% when infection occurs in the first trimester, and lower in later trimesters. However, because even mild Zika in pregnancy can cause severe outcomes, all exposure during pregnancy should be taken seriously and evaluated by a healthcare provider.
Yes, female-to-male sexual transmission is documented, though it appears to be less common than male-to-female transmission (possibly because viral persistence is longer and concentrations higher in semen). Transmission through oral sex is also documented. Both partners should take precautions after potential Zika exposure.
Yes. Zika remains endemic in parts of Latin America, the Caribbean, Pacific Islands, Southeast Asia, and sub-Saharan Africa. While the catastrophic 2015–2016 epidemic has subsided, the virus continues to circulate and cause both congenital Zika Syndrome and Guillain-Barré Syndrome in affected regions. Travel-associated cases continue to be reported globally.
CDC recommends waiting at least 3 months after symptom onset (or last possible exposure if asymptomatic) before trying to conceive if either partner has been exposed to Zika. This accounts for viral persistence in semen. Testing before attempting conception is advisable — consult your healthcare provider for personalized guidance.
Sources: WHO Zika situation reports; CDC Zika travel health notices; NEJM Zika and microcephaly (Mlakar et al. 2016); Lancet Infectious Diseases; Brasil et al., NEJM Zika congenital outcomes study; Musso & Gubler, Clinical Microbiology Reviews.
See also: Zika virus disease overview
Related: Zika disease page · Dengue · What is Zika?